PROGNOSTIC IMPACT OF SERUM CXC CHEMOKINE LIGANDS 4 AND 7 ON MYELODYSPLASTIC SYNDROMES POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT

Por DHAKAL, BINOD, WANG, TAO, HAAGENSON, MICHAEL, ZHU, FENLU, TAYLOR, CAROLYN, FENLU, SPELLMAN, STEPHEN R., VERNERIS, MICHAEL R., HSU, KATHARINE, FLEISCHHAUER, KATHARINA, LEE, STEPHANIE J., BOLON, YUNG-TSI, CARLSON, KAREN-SUE, NAZHA, AZIZ, SABER, WAEL
Publicado no Leuk Lymphoma (2020)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

Por Drobyski, William R., Szabo, Aniko, Zhu, Fenlu, Keever-Taylor, Carolyn, Hebert, Kyle M., Dunn, Renee, Yim, Sharon, Johnson, Bryon, D’Souza, Anita, Eapen, Mary, Fenske, Timothy S., Hari, Parameswaran, Hamadani, Mehdi, Horowitz, Mary M., Rizzo, J. Douglas, Saber, Wael, Shah, Nirav, Shaw, Bronwen, Pasquini, Marcelo
Publicado no Haematologica (2018)

A colitogenic memory CD4(+) T cell population mediates gastrointestinal graft-versus-host disease

Por Zhou, Vivian, Agle, Kimberle, Chen, Xiao, Beres, Amy, Komorowski, Richard, Belle, Ludovic, Taylor, Carolyn, Zhu, Fenlu, Haribhai, Dipica, Williams, Calvin B., Verbsky, James, Blumenschein, Wendy, Sadekova, Svetlana, Bowman, Eddie, Ballantyne, Christie, Weaver, Casey, Serody, David A., Vincent, Benjamin, Serody, Jonathan, Cua, Daniel J., Drobyski, William R.
Publicado no J Clin Invest (2016)

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation

Por Chhabra, Saurabh, Visotcky, Alexis, Pasquini, Marcelo C., Zhu, Fenlu, Tang, Xiaoying, Zhang, Mei-Jie, Thompson, Robert, Abedin, Sameem, D’Souza, Anita, Dhakal, Binod, Drobyski, William R., Fenske, Timothy S., Jerkins, James H., Rizzo, J. Douglas, Runaas, Lyndsey, Saber, Wael, Shah, Nirav N., Shaw, Bronwen E., Horowitz, Mary M., Hari, Parameswaran N., Hamadani, Mehdi
Publicado no Biol Blood Marrow Transplant (2020)